ABVC BioPharma, Inc. (ABVC) Gross margin 2019–2025
ABVC BioPharma, Inc. (ABVC) gross margin by fiscal year — reported gross profit divided by reported revenue.
171.9%FY2025 · since FY2019: -25.4% → 171.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 171.9% | +201.3 pp |
| FY2024 | -29.4% | -477.7 pp |
| FY2023 | 448.3% | +412.2 pp |
| FY2022 | 36.2% | -94.3 pp |
| FY2021 | 130.5% | -10.6 pp |
| FY2020 | 141.1% | +166.5 pp |
| FY2019 | -25.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Net marginABVC Gross profitABVC Operating incomeABVC Operating marginABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →